| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Lodotra 5 mg, Tabletten mit veränderter Wirkstofffreisetzung | | 60494 | | 03 | | Lodotra 5 mg | | Tabletten mit veränderter Wirkstofffreisetzung | | H02AB07 | | Prednisone | | 26.08.2011 | | |
| | Composition | | prednisonum 5.00 mg, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 0.96 mg, calcii hydrogenophosphas dihydricus, glyceroli dibehenas, lactosum monohydricum 38.80 mg, magnesii stearas, povidonum, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | | | | | | Active Agent | Dose |
|---|
| Prednisone | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Prednisone | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | Calcium Hydrogen Phosphate Dihydrate | | | | | | | | | | color. | | | | | | Lactose Monohydrate | 38.8 mg | | | | | | | Povidone | | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
